Moderna Inc (MRNA)
126.88
-2.02
(-1.57%)
USD |
NASDAQ |
Jun 06, 16:00
127.15
+0.27
(+0.21%)
After-Hours: 19:48
Moderna Research and Development Expense (Annual): 3.295B for Dec. 31, 2022
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 3.295B |
| December 31, 2021 | 1.991B |
| December 31, 2020 | 1.37B |
| December 31, 2019 | 496.00M |
| Date | Value |
|---|---|
| December 31, 2018 | 454.08M |
| December 31, 2017 | 410.46M |
| December 31, 2016 | 274.72M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
454.08M
Minimum
2018
3.295B
Maximum
2022
1.521B
Average
1.37B
Median
2020
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 15.39B |
| Merck & Co Inc | 13.55B |
| Pfizer Inc | 11.43B |
| Eli Lilly and Co | 7.191B |
| Novavax Inc | 1.235B |